Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Vigneri

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
Anticancer Research|July 1, 2015
Several Site-specific Cancers are Increased in the Volcanic Area in SicilyMarco Russo, Pasqualino Malandrino, Walter Pollina Addario, et al.
Frontiers in Pharmacology|May 17, 2021
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?Federica Martorana, Gianmarco Motta, Giuliana Pavone, et al.
Diagnostics (Basel, Switzerland)|September 23, 2022
Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the LiteratureGiuliana Pavone, Chiara Romano, Federica Martorana, et al.
Current Oncology (Toronto, Ont.)|April 27, 2026
Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative ReviewMaria Rosaria Valerio, Daniela Sambataro, Federica Martorana, et al.
Current Cancer Drug Targets|January 6, 2016
Roles of Interferon Regulatory Factors in Chronic Myeloid LeukemiaLivia Manzella, Elena Tirrò, Maria Stella Pennisi, et al.
Annals of Translational Medicine|April 19, 2018
Ground glass opacities management in the lung cancer screening eraMarcello Migliore, Mariaconcetta Fornito, Manuela Palazzolo, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 28, 2023
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in ItalyVittorio Gebbia, Federica Martorana, Giuseppina Scandurra, et al.
Expert Review of Anticancer Therapy|March 19, 2022
Ribociclib efficacy in special populations and analysis of patient-reported outcomes in the MONALEESA trialsMaria V Sanò, Federica Martorana, Giuseppe Lavenia, et al.
Critical Reviews in Oncology/Hematology|April 18, 2021
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistanceSilvia Rita Vitale, Federica Martorana, Stefania Stella, et al.
Anticancer Research|September 29, 2023
Outcomes of Sentinel Lymph Node Biopsy for Patients With Node-positive Breast Cancer Treated With Neoadjuvant ChemotherapyCalogero Cipolla, Salvatore Vieni, Eleonora D'Agati, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
Anticancer Research|July 1, 2015
Several Site-specific Cancers are Increased in the Volcanic Area in SicilyMarco Russo, Pasqualino Malandrino, Walter Pollina Addario, et al.
Frontiers in Pharmacology|May 17, 2021
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?Federica Martorana, Gianmarco Motta, Giuliana Pavone, et al.
Diagnostics (Basel, Switzerland)|September 23, 2022
Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the LiteratureGiuliana Pavone, Chiara Romano, Federica Martorana, et al.
Current Oncology (Toronto, Ont.)|April 27, 2026
Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative ReviewMaria Rosaria Valerio, Daniela Sambataro, Federica Martorana, et al.
Current Cancer Drug Targets|January 6, 2016
Roles of Interferon Regulatory Factors in Chronic Myeloid LeukemiaLivia Manzella, Elena Tirrò, Maria Stella Pennisi, et al.
Annals of Translational Medicine|April 19, 2018
Ground glass opacities management in the lung cancer screening eraMarcello Migliore, Mariaconcetta Fornito, Manuela Palazzolo, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 28, 2023
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in ItalyVittorio Gebbia, Federica Martorana, Giuseppina Scandurra, et al.
Expert Review of Anticancer Therapy|March 19, 2022
Ribociclib efficacy in special populations and analysis of patient-reported outcomes in the MONALEESA trialsMaria V Sanò, Federica Martorana, Giuseppe Lavenia, et al.
Critical Reviews in Oncology/Hematology|April 18, 2021
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistanceSilvia Rita Vitale, Federica Martorana, Stefania Stella, et al.
Anticancer Research|September 29, 2023
Outcomes of Sentinel Lymph Node Biopsy for Patients With Node-positive Breast Cancer Treated With Neoadjuvant ChemotherapyCalogero Cipolla, Salvatore Vieni, Eleonora D'Agati, et al.
Pageof 15